The increasing expansion and the rising demand for food require a greater intensification in the production of Nile tilapia (Oreochromis niloticus), and genetic improvement programs are essential to achieve this goal. In managing these programs, new genetic material is introduced after several generations of selections to reduce inbreeding and enhance genetic diversity. In this sense, analyzing the zootechnical parameters of these introductions, with an emphasis on the use of nutritional additives, is of great importance for understanding their impact on breeding programs. Thus, the aim of this study was to evaluate the zootechnical parameters and hepatosomatic index of two genetic strains of Nile tilapia from the genetic improvement program fed with β-Glucan + Mannan oligosaccharide (βG+MOS). This study utilized a 2 × 2 factorial design containing two genetic groups and two treatments with βG+MOS (Control, 0.2%). The groups were formed from the 12th generation of the Tilamax genetic improvement program (TILAMAX) and by crossing Tilamax with an introduced test strain (CBTILAMAX). In total, 96 tilapias (31.1 ± 5.73 g) were distributed into 16 aquariums, with 6 fish per aquarium, 24 per group, and four repetitions. The experimental period lasted for 41 days, and the water parameters were measured daily and maintained under ideal conditions. The condition factor and hepatosomatic index were analyzed. Final weight, total length, and standard length were measured, and other zootechnical parameters were calculated based on these data. The condition factor showed that the fish in both groups exhibited adequate health and growth during the experiment, with no differences in strain or use of additives. Similarly, the hepatosomatic index did not differ between the groups, indicating that liver size was proportional to fish body size. Similarly, no significant differences (P>0.05) were observed for the other zootechnical parameters evaluated (initial and final total and standard lengths, final weight, total weight gain, condition factor using total and standard lengths, and specific growth rate). Based on these results, it is concluded that there were no differences between TILAMAX and CBTILAMAX related to performance and health under the effect of feeding with βG+MOS. This result is positive regarding the introduction of the test strain into the Tilamax genetic improvement program and establishes a starting point for further research that may provide greater clarity on its future effects.
Read full abstract